Novo Nordisk

Study:-Vision-Risk-with-Wegovy,-Ozempic-The-Aartery-Chronicles-TAC

Study: Vision Risk with weightloss drug Wegovy

Reading Time: 2 minutes The research, published in JAMA Ophthalmology, highlights potential risks associated with the active ingredient semaglutide

Study: Vision Risk with weightloss drug Wegovy Read More »

July 10, 2024

biopharma-summit-the-aartery-chronicles-tac

US FDA Commissioner Praises India Ahead of BioPharma Summit

Reading Time: 2 minutes US FDA Commissioner highlights India’s role in medical sector ahead of BioPharma Summit, emphasizing collaboration and quality standards.

US FDA Commissioner Praises India Ahead of BioPharma Summit Read More »

Health News

April 23, 2024

37006